TABLE 1.

Patient characteristics

Patient	Treatment duration (mo)			CD4 count (cells/mm3)	Viral load (log10 copies/ml)
	R18893	Loviride	Othera
B701	None	40	None	191	5.74
B702	6	28	None	578	4.68
B703	None	35	None	282	4.05
B704	None	39	None	235	5.18
B705	None	29	None	387	4.08
B706	None	23	None	519	4.66
B707	None	24	None	578	3.84
B708	None	30	None	336	4.77
B709	6	30	None	465	4.62
B710	None	17	ZDV, 9; Ind, 2	259	3.74
B711	None	38	None	548	4.34
B712	None	29	None	495	3.63
B713	None	39	None	447	2.70
B714	6	27	None	306	5.85
B715	None	28	None	628	4.54
B716	None	28	ZDV, 3; 3TC, 3	271	4.90
B717	2	5	None	492	5.36
B718	None	39	None	598	5.71
B719	None	42	None	818	5.25
B720	None	8	None	727	2.70
B721	None	21	None	168	5.44
B722	None	28	None	409	3.04
B723	None	29	None	294	4.71
B724	None	31	None	460	3.28
B725	None	26	None	297	5.89
B726	2	28	None	376	4.92
Median		28.5		428	4.67

^aInd, indinavir; 3TC, lamivudine.